Boutique Diagnostics

Digital Health Market Access Consulting Firm

Digital Health Solutions

Digital boost for Atrial Fibrillation detection and monitoring

Digital boost for Atrial Fibrillation detection and monitoring

Atrial fibrillation (AF) is the most common type of cardiac arrhythmia affecting over 11 million people in Europe. The disease area has attracted the attention from an array of innovative digital diagnostics companies. This article provides a summary of a few key digital Afib solutions.

Later this month join us in the second part of our 2-part series on AF, where we discuss AF risk scores, another area of progress in AF diagnostics.

Germany’s Digital Healthcare Act – A glimpse on the first applicants

Germany’s Digital Healthcare Act – A glimpse on the first applicants

Digital Healthcare Act (DiGAV) aims to create a solid reimbursement pathway for digital health solutions in the German healthcare market. BfArM, the body that determines which solution will be enlisted in the DiGA registry, opened its application portal in May, and it is expected to publish the first application results later this month.

Meanwhile, the umbrella association for digital healthcare acts (Spitzenverband Digitale Gesundheitsversorgung) has disclosed some of the first companies that applied for inclusion in the DiGA registry.

What’s hot in the world of (digital) diagnostics? A few highlights for August 2020

What’s hot in the world of (digital) diagnostics? A few highlights for August 2020

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives

Cost cutting in the Swiss Healthcare System (diagnostics perspective)

Cost cutting in the Swiss Healthcare System (diagnostics perspective)

Swiss healthcare minister Alain Berset has announced intentions to save 1 billion CHF for the healthcare system, whilst improving care efficiency. To achieve this goal, 9 initiatives were proposed on the 19th of August, which are now undergoing public consultation.

The following is Centivis’ current understanding based on publicly available documents. However, we acknowledge that the situation may change depending on the results of the public consultation.

What’s new in the world of diagnostics? A few highlights for July 2020

What’s new in the world of diagnostics? A few highlights for July 2020

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

Download Insights – Prostate Cancer Diagnostics Solutions

Download Insights – Prostate Cancer Diagnostics Solutions

Prostate cancer is the 2nd most commonly diagnosed cancer amongst men. Many men also go through invasive biopsies that yield negative results.

What tests are used to diagnose prostate cancer, minimize invasive biopsies, and improve prognosis? Check out our short report.

What’s hot in (digital) diagnostics? – News in bullets, June - 2020

What’s hot in (digital) diagnostics? – News in bullets, June - 2020

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Spotlight on Germany’s Digital Healthcare Reimbursement Pathway

Spotlight on Germany’s Digital Healthcare Reimbursement Pathway

Germany’s digital healthcare market is about to open up, thanks to the Digital Healthcare Act (DiGAV), which puts in place a solid reimbursement pathway for digital health solutions. In this blog post, we answer some frequently asked questions, relevant to market access, with insights from recently published documents/conferences on the topic.

What’s hot in (digital) diagnostics? – News in bullets, April - 2020

What’s hot in (digital) diagnostics?  – News in bullets, April - 2020

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

What’s hot in (digital) diagnostics? – News in bullets, March - 2020

What’s hot in (digital) diagnostics?  – News in bullets, March - 2020

Exciting (NON-Covid19) news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

Switzerland – New Highly Specialized Rare Disease Diagnostic Tests Reimbursed

Switzerland – New Highly Specialized Rare Disease Diagnostic Tests Reimbursed

Switzerland regularly updates the Analysenliste (AL), a comprehensive list of diagnostic tests that are covered by compulsory health insurance. As of April 2020, among others, the following new rare disease genetic tests will be added to the list:

What’s hot in (digital) diagnostics? – News in bullets, January - 2020

What’s hot in (digital) diagnostics?  – News in bullets, January - 2020

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.